Skip to content

Coronary Artery Study in Pediatric Heart Transplantation

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01546870
Acronym
CAS-POHT
Enrollment
0
Registered
2012-03-07
Start date
2012-04-30
Completion date
2012-04-30
Last updated
2016-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Transplant Coronary Artery Disease

Brief summary

Transplant coronary artery disease (TCAD) is a significant cause of morbidity and mortality in pediatric heart transplantation (PHT). Understanding the pathophysiology and early detection along with attempted medical management are crucial in preventing advancement of the disease and retransplantation or mortality. Coronary angiogram, although routinely used is insensitive to detect early TCAD. Measurement of fractional flow reserve (FFR), coronary flow reserve (CFR) and index of microvascular resistance (IMR) using a doppler pressure and flow intracoronary wire may be more sensitive in evaluating the integrity of coronary vasculature and thus detect pre clinical TCAD. To the best of the investigators knowledge, measurement of these parameters has not been previously reported in PHT.

Interventions

None listed

Sponsors

University of Arkansas
CollaboratorOTHER
Arkansas Children's Hospital Research Institute
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* less than 21 years and above 7 years of age

Exclusion criteria

* clinically significant coronary artery disease on angiography and inability to undergo IVUS

Design outcomes

Primary

MeasureTime frame
Clinical coronary artery disease1 year

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026